PL2229950T3 - Zastosowanie roślin z gatunku sideritis i ich ekstraktów do leczenia zespołu nadpobudliwości psychoruchowej z deficytem uwagi - Google Patents
Zastosowanie roślin z gatunku sideritis i ich ekstraktów do leczenia zespołu nadpobudliwości psychoruchowej z deficytem uwagiInfo
- Publication number
- PL2229950T3 PL2229950T3 PL10002550T PL10002550T PL2229950T3 PL 2229950 T3 PL2229950 T3 PL 2229950T3 PL 10002550 T PL10002550 T PL 10002550T PL 10002550 T PL10002550 T PL 10002550T PL 2229950 T3 PL2229950 T3 PL 2229950T3
- Authority
- PL
- Poland
- Prior art keywords
- plants
- extracts
- attention deficit
- sideritis
- genus
- Prior art date
Links
- 239000000284 extract Substances 0.000 title abstract 3
- 208000036864 Attention deficit/hyperactivity disease Diseases 0.000 title 1
- 241000196324 Embryophyta Species 0.000 title 1
- 235000012864 Sideritis Nutrition 0.000 title 1
- 241000011901 Sideritis Species 0.000 title 1
- 208000015802 attention deficit-hyperactivity disease Diseases 0.000 title 1
- DUGOZIWVEXMGBE-UHFFFAOYSA-N Methylphenidate Chemical compound C=1C=CC=CC=1C(C(=O)OC)C1CCCCN1 DUGOZIWVEXMGBE-UHFFFAOYSA-N 0.000 abstract 1
- 210000004556 brain Anatomy 0.000 abstract 1
- 230000006735 deficit Effects 0.000 abstract 1
- 230000002825 dopamine reuptake Effects 0.000 abstract 1
- 239000000221 dopamine uptake inhibitor Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 208000013403 hyperactivity Diseases 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 230000010534 mechanism of action Effects 0.000 abstract 1
- 229960001344 methylphenidate Drugs 0.000 abstract 1
- 230000001777 nootropic effect Effects 0.000 abstract 1
- 239000002767 noradrenalin uptake inhibitor Substances 0.000 abstract 1
- 229940126569 noradrenaline reuptake inhibitor Drugs 0.000 abstract 1
- 208000011580 syndromic disease Diseases 0.000 abstract 1
- 229940125725 tranquilizer Drugs 0.000 abstract 1
- 239000003204 tranquilizing agent Substances 0.000 abstract 1
- 230000002936 tranquilizing effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Alternative & Traditional Medicine (AREA)
- Psychiatry (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102009013225A DE102009013225A1 (de) | 2009-03-17 | 2009-03-17 | Verwendung von Pflanzen der Gattung Sideritis und Extrakten daraus zur Behandlung des Aufmerksamkeitsdefizit-Hyperaktivitätssyndroms |
| EP10002550A EP2229950B1 (de) | 2009-03-17 | 2010-03-11 | Verwendung von Pflanzen der Gattung Sideritis und Extrakten daraus zur Behandlung des Aufmerksamkeitsdefizit-Hyperaktivitätssyndroms |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2229950T3 true PL2229950T3 (pl) | 2011-11-30 |
Family
ID=42307868
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL10002550T PL2229950T3 (pl) | 2009-03-17 | 2010-03-11 | Zastosowanie roślin z gatunku sideritis i ich ekstraktów do leczenia zespołu nadpobudliwości psychoruchowej z deficytem uwagi |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP2229950B1 (pl) |
| AT (1) | ATE513554T1 (pl) |
| DE (1) | DE102009013225A1 (pl) |
| ES (1) | ES2368689T3 (pl) |
| PL (1) | PL2229950T3 (pl) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2608798B2 (de) | 2010-08-27 | 2018-11-07 | Finzelberg GmbH & Co. KG | Pflanzenextrakte aus gliedkräutern und deren verwendung zur steigerung kognitiver leistungsfähigkeit |
| GR1007678B (el) * | 2011-06-17 | 2012-08-30 | Δημητριος Νικολαου Πολιτοπουλος | Ετοιμο προς καταναλωση ροφημα τσαγιου απο αφεψημα του βοτανου "τσαι του βουνου" και μεθοδος παραγωγης του |
| KR20210138559A (ko) | 2018-11-14 | 2021-11-19 | 핀젤베르크 게엠베하 운트 코.카게 | 세로토닌, 도파민, 노르아드레날린의 군으로부터 선택된 신경전달물질의 신경, 대뇌 이용성을 증가시키기 위한 레몬 버베나 (Aloysia citriodora) 잎 추출물의 용도 |
-
2009
- 2009-03-17 DE DE102009013225A patent/DE102009013225A1/de not_active Withdrawn
-
2010
- 2010-03-11 ES ES10002550T patent/ES2368689T3/es active Active
- 2010-03-11 AT AT10002550T patent/ATE513554T1/de active
- 2010-03-11 PL PL10002550T patent/PL2229950T3/pl unknown
- 2010-03-11 EP EP10002550A patent/EP2229950B1/de active Active
Also Published As
| Publication number | Publication date |
|---|---|
| DE102009013225A1 (de) | 2010-09-23 |
| EP2229950A1 (de) | 2010-09-22 |
| ATE513554T1 (de) | 2011-07-15 |
| EP2229950B1 (de) | 2011-06-22 |
| ES2368689T3 (es) | 2011-11-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2009137462A3 (en) | Methods for treating cognitive disorders using inhibitors of histone deacetylase | |
| BRPI1010302A2 (pt) | composições e métodos para tratamento, inibição ou prevenção do desenvolvimento de uma doença patogênica de planta e método de extermínio, inibição ou prevenção do desenvolvimento de um organismo | |
| UY32456A (es) | Composicion famaceutica, forma farmaceutica, procedimiento para su preparación, metodos de tratamiento | |
| WO2011073279A3 (fr) | Procédé de traitement cosmétique impliquant un composé apte à condenser in situ | |
| EP3598980A3 (en) | Compositions and methods to regulate renalase in the treatment of diseases and disorders | |
| WO2010129746A3 (en) | Treatment of tristetraproline (ttp) related diseases by inhibition of natural antisense transcript to ttp | |
| WO2008116920A3 (de) | 17beta-hydroxysteroid-dehydrogenase-typ1-inhibitoren zur behandlung hormonabhängiger erkrankungen | |
| WO2012042404A3 (en) | Antimicrobial, antibacterial and spore germination inhibiting activity from an avocado extract enriched in bioactive compounds | |
| BR112012001372A2 (pt) | comprimido, e, métodos para preparar um comprimido e para a profilaxia ou tratamento de hiperfosfatemia. | |
| WO2010139410A3 (de) | Verwendung von succinat dehydrogenase inhibitoren zur kontrolle von sclerotinia ssp | |
| WO2007104053A3 (en) | 8-heteroarylpurine mnk2 inhibitors for treating metabolic disorders | |
| TN2011000187A1 (en) | Organic compounds | |
| MX2010007490A (es) | Preparacion de derivados de sulfamida. | |
| HK1213471A1 (zh) | 作為蛋白脫乙酰基酶抑制劑的嘧啶羥基酰胺化合物及其使用方法 | |
| WO2012009402A3 (en) | Treatment of discs large homolog (dlg) related diseases by inhibition of natural antisense transcript to dlg | |
| BR112013004456A2 (pt) | composição para tratamento de planta, e, método para o tratamento de plantas | |
| WO2012071238A3 (en) | Treatment of nanog related diseases by inhibition of natural antisense transcript to nanog | |
| DK2310003T3 (da) | Inhibitorer af Carnitin-Palmitoyl-Transferase-1 til behandling og forebyggelse af lidelser forårsaget af delipidering af neuralt væv | |
| MX370253B (es) | Composiciones de compuestos de jasmonato y métodos de uso de las mismas. | |
| AU2011322715A8 (en) | Treatment of MeCP2-associated disorders | |
| EA201170672A1 (ru) | Соединения, пригодные для лечения целлюлита | |
| WO2009102789A3 (en) | Use of rxr agonists for the treatment of osteroarthritis | |
| WO2010098583A3 (ko) | 스타틴 화합물 또는 그 염의 신규 제조방법, 및 이에 사용되는 중간체 화합물 | |
| PT2515922E (pt) | Extractos vegetais para o tratamento de doenças neurodegenerativas | |
| WO2011028890A3 (en) | Compositions and methods for treatment of neuropathic pain |